Advanced Enzyme (ADVENZYMES)
STALWARTFairStock Score: 19/100 — RISKY
Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹298.85 |
| Market Cap | ₹3,361.16 Cr |
| P/E Ratio | 23.33 |
| ROCE | 13.11% |
| ROE | 20.02% |
| Dividend Yield | 1.73% |
| Profit Growth | -8.89% |
| Debt/Equity | 0.02 |
| Sales Growth | 1.68% |
| Promoter Holding | 43.04% |
| 52-Week Range | ₹251.95 — ₹419.8 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹53.29 |
Advanced Enzyme trades with a P/E ratio of 23.33, ROCE of 13.11%, ROE of 20.02%, profit growth of -8.89%, debt-to-equity of 0.02. The FairStock Score of 19/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer